These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 15161983

  • 1. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study.
    Stoll T, Sutcliffe N, Mach J, Klaghofer R, Isenberg DA.
    Rheumatology (Oxford); 2004 Aug; 43(8):1039-44. PubMed ID: 15161983
    [Abstract] [Full Text] [Related]

  • 2. Lupus disease activity and the risk of subsequent organ damage and mortality in a large lupus cohort.
    Lopez R, Davidson JE, Beeby MD, Egger PJ, Isenberg DA.
    Rheumatology (Oxford); 2012 Mar; 51(3):491-8. PubMed ID: 22109798
    [Abstract] [Full Text] [Related]

  • 3. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB, Ibañez D, Jerome D, Gladman DD.
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [Abstract] [Full Text] [Related]

  • 4. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC, Ho LY, Cheung MY, Yu KL, To CH.
    Scand J Rheumatol; 2009 Nov; 38(2):121-7. PubMed ID: 18991189
    [Abstract] [Full Text] [Related]

  • 5. Do present damage and health perception in patients with systemic lupus erythematosus predict extent of future damage?: a prospective study.
    Stoll T, Sutcliffe N, Klaghofer R, Isenberg DA.
    Ann Rheum Dis; 2000 Oct; 59(10):832-5. PubMed ID: 11005787
    [Abstract] [Full Text] [Related]

  • 6. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
    Hanly JG, McCurdy G, Fougere L, Douglas JA, Thompson K.
    J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
    [Abstract] [Full Text] [Related]

  • 7. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality.
    Becker-Merok A, Nossent HC.
    J Rheumatol; 2006 Aug; 33(8):1570-7. PubMed ID: 16845708
    [Abstract] [Full Text] [Related]

  • 8. Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort study.
    Cardoso CR, Signorelli FV, Papi JA, Salles GF.
    Lupus; 2008 Nov; 17(11):1042-8. PubMed ID: 18852231
    [Abstract] [Full Text] [Related]

  • 9. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
    Nived O, Jönsen A, Bengtsson AA, Bengtsson C, Sturfelt G.
    J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
    [Abstract] [Full Text] [Related]

  • 10. Accrual of organ damage over time in patients with systemic lupus erythematosus.
    Gladman DD, Urowitz MB, Rahman P, Ibañez D, Tam LS.
    J Rheumatol; 2003 Sep; 30(9):1955-9. PubMed ID: 12966597
    [Abstract] [Full Text] [Related]

  • 11. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus.
    Stoll T, Gordon C, Seifert B, Richardson K, Malik J, Bacon PA, Isenberg DA.
    J Rheumatol; 1997 Aug; 24(8):1608-14. PubMed ID: 9263159
    [Abstract] [Full Text] [Related]

  • 12. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
    Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P.
    J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
    [Abstract] [Full Text] [Related]

  • 13. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T, Fierz W, Stoll T, Villiger PM.
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [Abstract] [Full Text] [Related]

  • 14. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.
    Leandro MJ, Cambridge G, Edwards JC, Ehrenstein MR, Isenberg DA.
    Rheumatology (Oxford); 2005 Dec; 44(12):1542-5. PubMed ID: 16188950
    [Abstract] [Full Text] [Related]

  • 15. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women.
    Fernández M, Calvo-Alén J, Alarcón GS, Roseman JM, Bastian HM, Fessler BJ, McGwin G, Vilá LM, Sanchez ML, Reveille JD.
    Arthritis Rheum; 2005 Jun; 52(6):1655-64. PubMed ID: 15934092
    [Abstract] [Full Text] [Related]

  • 16. Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: anaemia as a predictor of disease activity and damage accrual.
    Bertoli AM, Vilá LM, Apte M, Fessler BJ, Bastian HM, Reveille JD, Alarcón GS, LUMINA Study Group.
    Rheumatology (Oxford); 2007 Sep; 46(9):1471-6. PubMed ID: 17650522
    [Abstract] [Full Text] [Related]

  • 17. The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected].
    Chaiamnuay S, Bertoli AM, Fernández M, Apte M, Vilá LM, Reveille JD, Alarcón GS, LUMINA Study Group.
    J Clin Rheumatol; 2007 Jun; 13(3):128-33. PubMed ID: 17551377
    [Abstract] [Full Text] [Related]

  • 18. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.
    Hiraki LT, Benseler SM, Tyrrell PN, Hebert D, Harvey E, Silverman ED.
    J Pediatr; 2008 Apr; 152(4):550-6. PubMed ID: 18346514
    [Abstract] [Full Text] [Related]

  • 19. Definition and treatment of lupus flares measured by the BILAG index.
    Gordon C, Sutcliffe N, Skan J, Stoll T, Isenberg DA.
    Rheumatology (Oxford); 2003 Nov; 42(11):1372-9. PubMed ID: 12810926
    [Abstract] [Full Text] [Related]

  • 20. A statistical analysis of the interrelationships between disease activity in different systems in systemic lupus erythematosus.
    Allen E, Farewell VT, Isenberg DA, Gordon C.
    Rheumatology (Oxford); 2006 Mar; 45(3):308-13. PubMed ID: 16249244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.